Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › IMCR

FARALLON CAPITAL MANAGEMENT, L.L.C. position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 928,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$28.1M, representing 0.12% of its reported portfolio and ranking #48 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. first reported this position in Q3 2026.

Latest position (Q3 2026)928.00K sh
Reported value held$28.11M
Portfolio Weight0.12%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s IMCR position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in IMCR in Q3 2026 at 928,000 shares (US$28.1M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 928.00K $28.11M New

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 26 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held IMCR?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed IMCR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in IMCR?

As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 928.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $28.11M, representing 0.12% of its reported portfolio and ranking #48.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling IMCR?

In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. newly opened its position in IMCR.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.